0001214659-20-006719.txt : 20200902 0001214659-20-006719.hdr.sgml : 20200902 20200803165231 ACCESSION NUMBER: 0001214659-20-006719 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200803 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANIGEN, INC CENTRAL INDEX KEY: 0001293310 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770557236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650.243.3100 MAIL ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20040609 CORRESP 1 filename1.htm

HUMANIGEN, INC.

533 Airport Boulevard, Suite 400

Burlingame, California 94010

August 3, 2020

BY EDGAR

Mr. Tim Buchmiller

Mr. Joseph McCann

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re:

Humanigen, Inc.

Registration Statement on Form S-1

File No. 333-239161

Ladies and Gentlemen:

The undersigned registrant hereby requests that the effectiveness of the above-captioned Registration Statement on Form S-1 be accelerated so that the same will become effective at 4:30 p.m. Eastern Time on August 5, 2020, or as soon thereafter as practicable.

Very truly yours,

HUMANIGEN, INC.

By:	/s/ Cameron Durrant
Name:	Cameron Durrant, M.D., MBA
Title:	Chairman of the Board and Chief Executive Officer

cc:

Kevin L. Vold